Strategic Global Advisors’s DexCom DXCM Stock Holding History

Strategic Global Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-21,186	Closed	-$1.42M	–	143
2024 Q3	$1.42M	Sell	21,186 -214	-1%	-$17.6K	0.28%	84
2024 Q2	$2.43M	Buy	21,400 +403	+2%	+$51K	0.51%	66
2024 Q1	$2.91M	Buy	20,997 +7,448	+55%	+$936K	0.63%	54
2023 Q4	$1.68M	Sell	13,549 -9,174	-40%	-$937K	0.39%	81
2023 Q3	$2.12M	Sell	22,723 -990	-4%	-$112K	0.35%	90
2023 Q2	$3.05M	Buy	+23,713	New	+$2.87M	0.47%	71

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Strategic Global Advisors's DXCM Position: Q4 2024 in Review

Strategic Global Advisors sold out of DexCom (DXCM) in Q4 2024, closing a stake of 21,186 shares — an estimated $1.42M sold.

Strategic Global Advisors first reported a position in DXCM in Q2 2023 and held it in 6 quarters. The position peaked at $3.05M in Q2 2023. 950 funds tracked by Wall St. Rank hold DXCM as of Q4 2024.

Strategic Global Advisors reported no remaining DexCom position as of Q4 2024 after selling out during the quarter.
Strategic Global Advisors sold 21,186 DexCom shares in Q4 2024, an estimated $1.42M.
Strategic Global Advisors first reported a position in DexCom in Q2 2023 and held it in 6 quarters.
Strategic Global Advisors's DexCom position peaked at $3.05M in Q2 2023.
950 funds tracked by Wall St. Rank held DexCom as of Q4 2024.

Based on Strategic Global Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.